P. Cortesi, G. Botto, Lucia S D'Angiolella, L. Scalone, Roberto De Ponti, G. Boriani, Lorenzo G. Mantovani
{"title":"可穿戴式心律转复除颤器在心肌梗死及ICD移植患者中的应用","authors":"P. Cortesi, G. Botto, Lucia S D'Angiolella, L. Scalone, Roberto De Ponti, G. Boriani, Lorenzo G. Mantovani","doi":"10.7175/FE.V22I1S.1486","DOIUrl":null,"url":null,"abstract":"The objective of the present work is to conduct a Health Technology Assessment (HTA) on the use of the Wearable Cardioverter Defibrillator (WCD) in patients at risk of Sudden Cardiac Arrest (SCA) following Myocardial Infarction (MI) or with an explanted Implantable Cardioverter Defibrillator (ICD).","PeriodicalId":41585,"journal":{"name":"Farmeconomia-Health Economics and Therapeutic Pathways","volume":"34 1","pages":""},"PeriodicalIF":0.4000,"publicationDate":"2021-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Health Technology Assessment on the use of the Wearable Cardioverter Defibrillator in Patients with Myocardial Infarction and with ICD Explant\",\"authors\":\"P. Cortesi, G. Botto, Lucia S D'Angiolella, L. Scalone, Roberto De Ponti, G. Boriani, Lorenzo G. Mantovani\",\"doi\":\"10.7175/FE.V22I1S.1486\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The objective of the present work is to conduct a Health Technology Assessment (HTA) on the use of the Wearable Cardioverter Defibrillator (WCD) in patients at risk of Sudden Cardiac Arrest (SCA) following Myocardial Infarction (MI) or with an explanted Implantable Cardioverter Defibrillator (ICD).\",\"PeriodicalId\":41585,\"journal\":{\"name\":\"Farmeconomia-Health Economics and Therapeutic Pathways\",\"volume\":\"34 1\",\"pages\":\"\"},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2021-04-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Farmeconomia-Health Economics and Therapeutic Pathways\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7175/FE.V22I1S.1486\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Farmeconomia-Health Economics and Therapeutic Pathways","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7175/FE.V22I1S.1486","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
Health Technology Assessment on the use of the Wearable Cardioverter Defibrillator in Patients with Myocardial Infarction and with ICD Explant
The objective of the present work is to conduct a Health Technology Assessment (HTA) on the use of the Wearable Cardioverter Defibrillator (WCD) in patients at risk of Sudden Cardiac Arrest (SCA) following Myocardial Infarction (MI) or with an explanted Implantable Cardioverter Defibrillator (ICD).